Pages that link to "Q34432972"
Jump to navigation
Jump to search
The following pages link to Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice (Q34432972):
Displaying 50 items.
- Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane (Q24314623) (← links)
- Antiangiogenesis cocktails - stirred or shaken? (Q24548357) (← links)
- New chemotherapy strategies and biological agents in the treatment of childhood ependymoma (Q24658324) (← links)
- Invasion and metastasis in pancreatic cancer (Q24800065) (← links)
- The Concept of Hormesis in Cancer Therapy - Is Less More? (Q26800519) (← links)
- The Contribution of Angiogenesis to the Process of Metastasis (Q26801841) (← links)
- Metronomic therapy for gynecologic cancers (Q26830493) (← links)
- Metronomic Chemotherapy--A New Path to Treat Advanced Non-small Cell Lung Cancer (Q27015786) (← links)
- Targeting the tumor vasculature to enhance T cell activity (Q27026329) (← links)
- Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations (Q27335464) (← links)
- Future paradigms for precision oncology (Q28078745) (← links)
- Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy (Q28253120) (← links)
- Patient perspectives: Tijuana cancer clinics in the post-NAFTA era (Q28306156) (← links)
- Angiogenesis: an organizing principle for drug discovery? (Q29614538) (← links)
- Sustained delivery of a HIF-1 antagonist for ocular neovascularization (Q30560557) (← links)
- Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma. (Q30846827) (← links)
- Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancer (Q33403308) (← links)
- Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma (Q33408052) (← links)
- Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy (Q33411816) (← links)
- Retrospective comparison of three doses of metronomic chlorambucil for tolerability and efficacy in dogs with spontaneous cancer. (Q33431916) (← links)
- Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice (Q33485606) (← links)
- Stability of cyclophosphamide in extemporaneous oral suspensions (Q33526743) (← links)
- Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy (Q33557868) (← links)
- FOXL2 suppresses proliferation, invasion and promotes apoptosis of cervical cancer cells (Q33582969) (← links)
- Angiogenesis inhibitors in the treatment of prostate cancer (Q33611121) (← links)
- Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer. (Q33780689) (← links)
- The toxicity of anti-VEGF agents when coupled with standard chemotherapeutics (Q33818307) (← links)
- Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy (Q33829569) (← links)
- Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine (Q33866374) (← links)
- A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function (Q33872982) (← links)
- Metronomic docetaxel in PRINT nanoparticles and EZH2 silencing have synergistic antitumor effect in ovarian cancer (Q33875597) (← links)
- Combination therapy in combating cancer (Q33914234) (← links)
- A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer (Q33916210) (← links)
- Anti-proliferative and angio-suppressive effect of Stoechospermum marginatum (C. Agardh) Kutzing extract using various experimental models (Q34006393) (← links)
- A role for survivin in chemoresistance of endothelial cells mediated by VEGF (Q34047896) (← links)
- Clinical translation of angiogenesis inhibitors (Q34152769) (← links)
- Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan (Q34173001) (← links)
- Neuroblastoma: biological insights into a clinical enigma (Q34180699) (← links)
- Antiangiogenic agents and their promising potential in combined therapy (Q34288928) (← links)
- Gene therapy of glioblastomas: from suicide to homicide (Q34361488) (← links)
- Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles (Q34403657) (← links)
- Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties (Q34420841) (← links)
- Building 'validated' mouse models of human cancer (Q34430852) (← links)
- Targeting angiogenesis with integrative cancer therapies (Q34495463) (← links)
- Metronomic scheduling: the future of chemotherapy? (Q34569946) (← links)
- Childhood acute lymphoblastic leukaemia--current status and future perspectives (Q34570023) (← links)
- Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy. (Q34975572) (← links)
- Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study (Q34993605) (← links)
- Recent developments in antiangiogenic therapy (Q35040867) (← links)
- Angiogenesis and apoptosis (Q35091135) (← links)